A digital health game to prevent opioid misuse and promote mental health in adolescents in school-based health settings: Protocol for the PlaySmart game randomized controlled trial.
A digital health game to prevent opioid misuse and promote mental health in adolescents in school-based health settings: Protocol for the PlaySmart game randomized controlled trial.
复制标题
DOI：
10.1371/journal.pone.0291298
复制
发表时间：
2023
期刊：
影响因子：
3.7
通讯作者：
中科院分区：
文献类型：
--
作者：
从事非阿片类药物滥用和/或经历精神健康症状的青少年滥用阿片类药物和/或发展阿片类药物使用障碍的风险更大。青少年是一个关键的发展时期，既可以防止阿片类药物滥用的开始，也可以针对心理健康。到目前为止，还没有针对这两种情况的数字健康游戏。我们描述了一项随机对照试验的协议，旨在评估原始数字健康游戏PlaySmart的疗效。532名16-19岁的青少年，谁是在启动阿片类药物滥用的风险更大，从康涅狄格州的10所学校为基础的健康站点招募。参与者被随机分配到PlaySmart或一组时间/注意力控制视频游戏。随机化按出生时的性别和学校年级分层。参与者玩他们指定的游戏长达六周（300分钟），并在12个月内完成评估问题（基线，游戏后，3，6和12个月）。主要结局是3个月时对阿片类药物滥用危害风险的感知。阿片类药物滥用的次要结果指标包括意图、自我效能、态度、知识和感知规范。心理健康结果包括抑郁（患者健康问卷-8），焦虑（广泛性焦虑症-7），寻求帮助的行为，耻辱，自我调节的措施，自我效能寻求心理健康的专业帮助，以及应对技能的知识。PlaySmart有可能显着降低阿片类药物滥用的风险，改善心理健康结果，并鉴于其高水平的参与度和可访问性，为青少年提供广泛的覆盖面，规模和影响力。试用注册：ClinicalTrials.gov：NCT 04941950。于二零二一年六月二十三日注册。
Adolescents who engage in non-opioid substance misuse and/or experience mental health symptoms are at greater risk of misusing opioids and/or developing opioid use disorder. Adolescence is a critical developmental period to both prevent the initiation of opioid misuse and target mental health. To date, there are no digital health games targeting both conditions. We describe the protocol for a randomized controlled trial designed to assess the efficacy of an original digital health game, PlaySmart. Five hundred and thirty-two adolescents aged 16–19 years old, who are at greater risk for initiating opioid misuse are recruited from 10 Connecticut school-based health sites. Participants are randomized to PlaySmart or a set of time/attention control videogames. Randomization was stratified by sex at birth and school grade. Participants play their assigned game or games for up to six weeks (300 minutes) and complete assessment questions over a 12-month period (baseline, post-gameplay, 3, 6, and 12 months). The primary outcome is perception of risk of harm of opioid misuse at 3 months. Secondary outcome measures specific to opioid misuse include intentions, self-efficacy, attitudes, knowledge, and perceived norms. Mental health outcomes include measures of depression (Patient Health Questionnaire-8), anxiety (Generalized Anxiety Disorder-7), help-seeking behaviors, stigma, measures of self-regulation, self-efficacy to seek professional help for mental health, and knowledge around coping skills. PlaySmart has the potential to significantly reduce the risk of initiation of opioid misuse, improve mental health outcomes, and given its high levels of engagement and accessibility, holds the promise for extensive reach, scale, and impact for adolescents. Trial registration: ClinicalTrials.gov: NCT04941950. Registered on 23 June 2021.
登录
查看更多内容
影响因子：
3.4
作者：
Skenderian, Jessica J.;Siegel, Jason T.;Crano, William D.;Alvaro, Eusebio E.;Lac, Andrew
通讯作者：
Lac, Andrew
影响因子：
7.4
作者：
Fiellin LE;Hieftje KD;Pendergrass TM;Kyriakides TC;Duncan LR;Dziura JD;Sawyer BG;Mayes L;Crusto CA;Forsyth BW;Fiellin DA
通讯作者：
Fiellin DA
影响因子：
7.4
作者：
Cunningham, Natoshia R.;Kashikar-Zuck, Susmita;Morgan, Esi M.
通讯作者：
Morgan, Esi M.
影响因子：
3.5
作者：
Duncan, Lindsay R.;Hieftje, Kimberly D.;Fiellin, Lynn E.
通讯作者：
Fiellin, Lynn E.
影响因子：
26.1
作者：
Gaither, Julie R.;Leventhal, John M.;Camenga, Deepa R.
通讯作者：
Camenga, Deepa R.